1-11 of 11
Michael Bennett
Close
Sort by
Journal Articles

Effective Gene Therapy for Hemophilia a: Novel Re-Dosable Non-Viral Formulation That Provides Stable, and Durable FVIII Expression with Improved Tolerability

Brian Truong, Khal Hajj, Johannes Schwerk, Dongyang Zhang, Johnnatan Tamayo, Gizem Guzelsoy, Joseph Kubicki, Alicia Davis, Lijun Huang, Gopi Vemuri, Kevin Johnson, Dan Smith, Jordan Bendor, Mu Li, Manjunath Goolyam, Daniel Abernathy, Pranav Nyshadham, Fernando Espinoza, Michelle Burrascano, James Yen, Kevin Briseno, Min Tong, Jen Beck, Joseph Lucas, Pavan Battiprolu, Michael Bennett, Blair Madison, Brent Warner, Eric Ostertag, Joshua Rychak
Journal: Blood
Blood (2023) 142 (Supplement 1): 1232.
https://doi.org/10.1182/blood-2023-189784
Published: 2023
Journal Articles

Cas-Clover Editing Efficiency and Off-Target Activity in Human Hepatocytes at the KLKB1 Locus

Oscar Alvarez, Lucas Homa, Stephanie Kearney, Khal Hajj, Zhibo Ma, Cindy Negron, Kevin Briseno, Matt Nitzahn, Nygel Oglesby, Mauricio Barajas-Mora, Arturo Barcenas, Joseph Kubicki, Alicia Davis, Mona Connerney, Pavan Battiprolu, Michael Bennett, Bonnie Jacques, Joshua Rychak, Brent Warner, Blair Madison
Journal: Blood
Blood (2023) 142 (Supplement 1): 7118.
https://doi.org/10.1182/blood-2023-189915
Published: 2023
Journal Articles

Sustained Factor VIII Activity Following Single Dose of Non-Viral Integrating Gene Therapy

Brian Truong, Giang N. Nguyen, Khal Hajj, Joseph Lucas, Johannes Schwerk, James Yen, Kevin Briseno, Michelle Burrascano, Daniel Smith, Johnnatan Tamayo, Fernando Lopez-Espinoza, Michael Bennett, Blair Madison, Denise E. Sabatino, Joshua Rychak
Journal: Blood
Blood (2022) 140 (Supplement 1): 969–970.
https://doi.org/10.1182/blood-2022-167919
Published: 2022
Journal Articles

Dexamethasone, Etoposide, Ifosfamide and Cisplatin (DVIP) as Salvage Therapy in Non-Hodgkin’s Lymphoma and Hodgkin’s Disease.

Yevgene Chubar, MD, Israel Gavish, MD, Shay Yegena, MD, Michael Bennett, MBBS FRCP FRCPath
Journal: Blood
Blood (2006) 108 (11): 4661.
https://doi.org/10.1182/blood.V108.11.4661.4661
Published: 2006
Journal Articles

HIF-2α regulates murine hematopoietic development in an erythropoietin-dependent manner

Marzia Scortegagna, Kan Ding, Quiyang Zhang, Yavuz Oktay, Michael J. Bennett, Michael Bennett, John M. Shelton, James A. Richardson, Orson Moe, Joseph A. Garcia
Journal: Blood
Blood (2005) 105 (8): 3133–3140.
https://doi.org/10.1182/blood-2004-05-1695
Published: 2005
Journal Articles

Killer cells protect themselves

Michael Bennett
Journal: Blood
Blood (2004) 104 (8): 2214.
https://doi.org/10.1182/blood-2004-07-2840
Published: 2004
Journal Articles

NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade

Crystal Y. Koh, John R. Ortaldo, Bruce R. Blazar, Michael Bennett, William J. Murphy
Journal: Blood
Blood (2003) 102 (12): 4067–4075.
https://doi.org/10.1182/blood-2003-04-1367
Published: 2003
Journal Articles

The HIF family member EPAS1/HIF-2α is required for normal hematopoiesis in mice

Marzia Scortegagna, Margaret A. Morris, Yavuz Oktay, Michael Bennett, Joseph A. Garcia
Journal: Blood
Blood (2003) 102 (5): 1634–1640.
https://doi.org/10.1182/blood-2003-02-0448
Published: 2003
Journal Articles

Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens

Arati Raziuddin, Dan L. Longo, Michael Bennett, Robin Winkler-Pickett, John R. Ortaldo, William J. Murphy
Journal: Blood
Blood (2002) 100 (8): 3026–3033.
https://doi.org/10.1182/blood.V100.8.3026
Published: 2002
Journal Articles

Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo

Crystal Y. Koh, Bruce R. Blazar, Thaddeus George, Lisbeth A. Welniak, Christian M. Capitini, Arati Raziuddin, William J. Murphy, Michael Bennett
Journal: Blood
Blood (2001) 97 (10): 3132–3137.
https://doi.org/10.1182/blood.V97.10.3132
Published: 2001
Journal Articles

Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2 b bone marrow cell allografts

Arati Raziuddin, Michael Bennett, Robin Winkler-Pickett, John R. Ortaldo, Dan L. Longo, William J. Murphy
Journal: Blood
Blood (2000) 95 (12): 3840–3844.
https://doi.org/10.1182/blood.V95.12.3840
Published: 2000